You are here: Industry Insights > GAVI

News List

$150 million made available for COVID-19 vaccine adverse event compensation scheme europeanpharmaceuticalreview
May 06, 2021
The COVAX No-fault Compensation Program will offer individuals in 92 lower-income countries and economies compensation for serious adverse events associated with COVID-19 vaccines distributed through COVAX.
Moderna to supply Covid-19 vaccine doses to Gavi pharmaceutical-technology
May 06, 2021
Moderna has entered an agreement with Gavi, the Vaccine Alliance, to deliver up to 500 million doses of its mRNA Covid-19 vaccine to help low- and middle-income countries fight the pandemic.
SII is legally bound to supply COVID-19 vaccines: COVAX expresspharma
April 12, 2021
The pact specified Gavi would receive from SII 1.1 billion doses of either the AstraZeneca vaccine or that of Novavax, with 200 million committed, and the rest on option.
India may make available fewer vaccines to the world as COVID-19 cases rise: Gavi expresspharma
April 07, 2021
We had expected, in March and April, about 90 million doses, and we suspect we'll get much, much less than that, and that is a problem, said Seth Berkley.
J&J single-shot COVID-19 vaccine gets Emergency Use Listing by WHO expresspharma
March 15, 2021
Data have demonstrated vaccine protects against COVID-19 related hospitalisation and death in broad geographic regions, including those with variants of significant concern.
AstraZeneca Advances Mass Global Rollout of COVID-19 Vaccine through COVAX americanpharmaceuticalreview
March 08, 2021
The first of AstraZeneca’s COVID-19 vaccine have begun arriving in low and middle-income countries across the world through the multilateral COVAX initiative, the first steps in fulfilling the Company’s efforts to provide broad and equitable access to ...
Gavi to make 500,000 doses of Ebola vaccine available for outbreak response europeanpharmaceuticalreview
January 25, 2021
The global stockpile will provide developing countries responding to Ebola outbreaks with doses of the approved single-dose Ebola vaccine, rVSV∆G-ZEBOV-GP, live, free of charge.
COVAX announces new agreement, plans for first deliveries worldpharmanews
January 25, 2021
COVAX announced the signing of an advance purchase agreement with Pfizer for up to 40 million doses of the Pfizer-BioNTech vaccine candidate, which has already received WHO emergency use listing.
Dr Harsh Vardhan nominated to the Board of GAVI, The Vaccine Alliance expresspharma
December 30, 2020
The Global Alliance for Vaccines and Immunisation (GAVI) has nominated Dr Harsh Vardhan, Union Minister of Health and Family Welfare as a member on the GAVI Board.
India may need $1.8 bn for first phase of COVID-19 vaccinations: GAVI expresspharma
December 18, 2020
India will have to spend $1.4 billion to $1.8 billion in the first phase of a coronavirus vaccination programme, even after getting support under the COVAX global vaccine-sharing scheme, according to estimates by the GAVI vaccines alliance.

Previous page 1 2 3 4 Next page